Intest Res > Volume 21(3); 2023 > Article |
|
Funding Source
This work has been supported by grants from the Ishibashi Foundation for the Promotion of Science (to Mizoguchi E), the Japan Society for the Women’s Health Science (to Mizoguchi E), the Fukuoka Clinical Medical Research Award (to Mizoguchi E), and the Japanese Society for the Promotion of Science to EM (18K07987 and 21K07996).
Author Contribution
Conceptualization: Mizoguchi E, Okada T, Sadanaga T, Minagawa T. Data curation: all authors. Formal analysis: Mizoguchi E, Okada T, Minagawa T, Akiba J. Funding acquisition: Mizoguchi E. Investigation: all authors. Methodology: all authors. Project administration: Mizoguchi E, Okada T, Minagawa T. Resources: Mizoguchi E. Software: Mizoguchi E, Okada T, Minagawa T. Supervision: Mizoguchi E, Akiba J. Validation: all authors. Visualization: all authors. Writing - original draft: Mizoguchi E, Okada T, Sadanaga T. Writing - review & editing: all authors. Approval of final manuscript: all authors.
Pros or cons | Study type | Outcome | Year | Reference |
---|---|---|---|---|
Inconclusive | Metabolomic study | There is a relationship between UC to disturbed glutathione metabolism and CAF metabolism. | 2022 | [81] |
Cons | Cross-section study | The higher intake of CAF was positively associated with irritable bowel disease prevalence. | 2021 | [80] |
Cons | Randomized study | CAF consumption is causally associated with the risk for CD or UC. | 2021 | [79] |
Pros | Population-based study | High CAF intake is protective against UC incidence in Australia. | 2016 | [82] |
Pros | In vivo (mouse) | CAF-treated mice developed lower tumors and milder inflammation than control in the murine model of colitis. | 2014 | [45] |
Pros | In vivo (mouse) | Oral CAF administration ameliorates acute colitis in a murine DSS colitis model. | 2014 | [74] |
Inconclusive | Cohort study | Sugar intake was higher in IBD patients from Eastern Europe than in Western Europe, while no geographic differences regarding CAF intake in these 2 regions. | 2014 | [83] |
Pros | In vitro (human) | CAF may reduce the inflammatory process in the colon. | 2012 | [9] |
Pros | Review article | Avoiding CAF would worsen clinical symptoms in IBD patients. | 2011 | [84] |
Inconclusive | Review article | Coffee and CAF have not been shown to be risk factors for diverticulitis but beneficial effects are still unclear. | 2008 | [85] |
Pros | In vivo (human) | Serum CAF profiles were significantly prolonged for the pH and time delivery system. | 2004 | [86] |
Pros or cons | Study type | Outcome | Year | Reference |
---|---|---|---|---|
Pros | In vitro (human) | CAF promotes apoptosis of colon cancer by inactivating PI3K/Akt signaling pathway. | 2022 | [87] |
Pros | In vivo (mouse) | CAF and chlorogenic acid combination suppress early-stage DMA/DCA-induced colon cancer in mice. | 2022 | [88] |
Pros | A case-control study | There is a significant protective effect of coffee against CRC in the overall and male populations. | 2022 | [89] |
Pros | In vitro (human) | Regular coffee consumption may display protective effects against CRC. | 2021 | [90] |
Cons | Meta-analysis | High levels of CAF intake are associated with the initiation and promotion of CRC. | 2020 | [49] |
Pros | In vitro (human) | CAF reduced the promotion of the S phase in DLD-1 human colon cancer cells. | 2020 | [91] |
Inconclusive | Meta-analysis | No evidence of the protective effect of coffee on CRC was found. | 2020 | [92] |
Pros | Follow-up study | CAF has a protective effect on CRC. | 2020 | [39] |
Pros | In vitro (human) | Low CAF-containing tea species induce mitochondria-dependent apoptosis in HCT116 human colon cancer cells. | 2020 | [93] |
Pros | In vitro (human) | CAF induces a significant increase in apoptosis of Dox-treated cells compared with proliferative cells. | 2020 | [94] |
Pros | Meta-analysis | CAF proved to exert a protective effect in men/women combined and in men alone for CRC but shows ethnicity. | 2019 | [95] |
Pros | In vivo (rat) | Coffee but not CAF decreased the development of colonic dysplastic crypts in the MNNG-exposed rat model. | 2019 | [96] |
Pros | Follow-up study | Intake of CAF and decaffeinated coffee after diagnosis of CRC results in a lower risk of CRC-specific death and overall death. | 2018 | [47] |
Pros | Meta-analysis | Coffee was associated with a probable decreased risk of CRC. | 2017 | [97] |
Pros | In vitro (human) | Low-dose coffee inhibited the proliferation of Caco-2 cells. | 2017 | [98] |
Cons | Prospective cohort study | Increased coffee consumption significantly increased colorectal tumor recurrence in the distal colon. | 2016 | [79] |
Pros | Prospective reported study | High coffee intake may significantly reduce cancer recurrence and death in advanced CRC patients. | 2015 | [99] |
Cons | In vitro (human) | CAF showed no significant cytotoxic effect in HT29 human CRC cells. | 2015 | [100] |
Pros | In vitro (human), in vivo (mouse) | CAF-treated mice developed fewer tumors and milder inflammation in a murine model of CRC. | 2014 | [45] |
Pros | In vitro (human) | Moderate coffee consumption is associated with a lower risk of CRC by reducing estrogen SULT activity. | 2013 | [101] |
Pros | Review article | Coffee may reduce CRC risk, increasing colon motility and antioxidant status. | 2012 | [102] |
Pros | Prospective study | Coffee was inversely associated with colon cancer, particularly proximal tumors. | 2012 | [48] |
Score | Definition |
---|---|
0 | No tumor |
1 | Low-grade dysplasia |
2 | High-grade dysplasia |
3 | Intra-mucosal adenocarcinoma (carcinoma in situ) |
4 | Invasive carcinoma |
5 | Distant metastasis |